Signalling by fibroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development

Bone

Volumn 34, Issue 1, 2004, Pages 13-25

  Amizuka, Norio ^a,h   Davidson, David ^b,c   Liu, Hanlong ^b,c   Valverde Franco, Gladys ^b,c   Chai, Sen ^b,c   Maeda, Takeyasu ^a   Ozawa, Hidehiro ^d   Hammond, Vicki ^e   Ornitz, David M ^f   Goltzman, David ^b,g   Henderson, Janet E ^b,c,g,h  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MATSUMOTO DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ROYAL VICTORIA HOSPITAL   (Canada)

^h NIIGATA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Chondrocyte; Differentiation; Proliferation; Vascular invasion

Indexed keywords

GROWTH FACTOR RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EPIPHYSEAL CARTILAGE; FACE DYSMORPHIA; FIBROBLAST; GENE EXPRESSION; HYPERTROPHY; LETHALITY; LIMB; LIMB DEVELOPMENT; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 0942278948     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2003.08.009     Document Type: Article

References (69)

1. Aarts M., Davidson D., Corluka A., Petroulakis E., Guo J., Bringhurst F.et al. PTHrP promotes quiescence and survival of serum deprived chondrocytes by inhibiting rRNA synthesis. J. Biol. Chem. 276:2001;37934-37943.
2. Aarts M., Guo R., Bringhurst R., Henderson J.E. The Nucleolar Targeting Signal (NTS) of parathyroid hormone related protein (PTHrP) mediate endocytosis and nuclear translocation. J. Bone Miner. Res. 14:1999;1493-1503.
3. Amizuka N., Chen M.F., Goodyer C., Ozawa H., Henderson J.E. Distinct growth plate abnormalities associated with mutations in the extracellular and intracellular domains of FGFR3 in thanatophoric dysplasia (TD). J. Bone Miner. Res. 14:1999;S187.
4. Amizuka N., Chen M.-F., Sasaki T., Asawa Y., Ozawa H., Henderson J. Abnormalities in development of the growth plates of thanatophoric dysplasia type II fetuses result from enhanced vascular invasion and osteoclastic activity. J. Bone Miner. Res. 16:2001;S187.
5. Amizuka N., Henderson J.E., Hoshi K., Warshawsky H., Ozawa H., Goltzman D.et al. Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion. Endocrinology. 137:1996;5055-5067.
6. Amizuka N., Karaplis A.C., Henderson J.E., Warshawsky H., Lipman M.L., Matsuki Y.et al. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal post-natal bone development. Dev. Biol. 175:1995;166-176.
7. Amizuka N., Kwan M., Goltzman D., Ozawa H., White J. Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone related peptide receptor expression in bone and cartilage. J. Clin. Invest. 103:1999;373-381.
8. Amizuka N., Lee H.S., Kwan M.Y., Azarani A., Warshawsky H., Hendy G.N.et al. Cell-specific expression of the parathyroid hormone (PTH)/PTH-related peptide receptor gene in kidney from kidney-specific and ubiquitous promoters. Endocrinology. 138:1997;469-481.
9. Amizuka N., Warshawsky H., Henderson J.E., Goltzman D., Karaplis A.C. Parathyroid hormone-related peptide (PTHrP)-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell Biol. 126:1994;1611-1623.
10. Amling M., Neff L., Tanaka S., Inoue D., Kuida K., Weir E.et al. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J. Cell Biol. 136:1997;205-213.
11. Baird A., Ornitz D.M. Fibroblast growth factors and their receptors. Canalis E. Skeletal growth factors. 2000;167-178 Lipincott Williams and Wilkins, Philadelphia.
12. Baran J., Klein K., Yanovski J., Novosad J., Bacher J., Bolander M.et al. Induction of growth plate cartilage ossification by basic fibroblast growth factor. Endocrinology. 135:1994;2790-2793.
13. Bernier S.M., Goltzman D. Regulation of expression of the chondrocytic phenotype in the skeletal cell line (CFK2) in vitro. J. Bone Miner. Res. 8:1993;475-484.
14. Bianco P., Cancedda F., Riminucci M., Cancedda R. Bone formation by cartilage models: the "borderline" chondrocyte. Matrix Biol. 17:1998;185-192.
15. Bove K.C., Koos R.D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 133:1993;829-837.
16. Bugler B., Amalric F., Prats H. Alternative initiation of translation b determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell. Biol. 11:1991;573-577.
17. Campbell J.S., Wenderoth M.P., Hauschka S.D., Krebs E.G. Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor. Proc. Natl. Acad. Sci. U. S. A. 92:1995;870-874.
18. Carlevaro M.F., Cermelli S., Cancedda R., Cancedda F.D. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: autocrine-paracrine role during endochondral bone formation. J. Cell Sci. 113:2000;59-69.
19. Chen L., Adar R., Yang X., Monsenago E., Li C., Hauschka P.et al. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting chondrogenesis and osteogenesis. J. Clin. Invest. 104:1999;1517-1525.
20. Chen L., Li C., Qiao W., Xu X., Deng C. A Ser365 to Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Hum. Mol. Genet. 10:2001;457-465.
21. Chung U., Schipani E., McMahon A.P., Kronenberg H.M. Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J. Clin. Invest. 2001;295-304.
22. Coffin J., Florkiewicz R., Neumann J., Mort-Hopkins T., Dorn G.W. 2nd, Lightfoot P.et al. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell. 6:1995;1861-1873.
23. Colvin J.S., Bohne B.A., Harding G.W., McEwen D.G., Ornitz D.M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12:1996;390-397.
24. D'Angelo M., Yan Z., Nooreyazdan M., Pacifici M., Sarment D.S., Billings P.C.et al. MMP-13 is induced during chondrocyte hypertrophy. J. Cell. Biochem. 77:2000;678-693.
25. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:1996;911-921.
26. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R.et al. Matrix Metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151:2000;879-889.
27. Farnum C., Wilson N. Determination of proliferative characteristics of growth plate chondrocytes by labeling with bromodeoxyuridine. Calcif. Tissue Int. 52:1993;110-119.
28. Farnum C.E., Wilsman N.J. Condensation of hypertrophic chondrocytes at the chondro-osseous junction of growth plate cartilage in Yucatan swine: relationship to long bone growth. Am. J. Anat. 186:1989;346-358.
29. Gerber H., Vu T., Ryan A., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:1999;623-628.
30. Guo J., Lanske B., Liu B.Y., Divieti P., Kronenberg H.M., Bringhurst F.R. Signal selectivity of parathyroid hormone (PTH) PTH-related peptide receptor mediated regulation of differentiation in conditionally immortalized growth plate chondrocytes. Endocrinology. 142:2001;1260-1268.
31. Henderson J., Kremer R., Goltzman D. Systemic factors in skeletal manifestations of malignancy. Bilezekian J., Raisz L., Rodan G. Principles of bone biology. vol. 2:2002;1079-1092 Academic Press, New York.
32. Henderson J.E., Amizuka N., Warshawsky H., Biasotto D., Lanske B.M.K., Goltzman D.et al. Nucleolar targeting of PTHrP enhances survival of chondrocytes under conditions that promote cell death by apoptosis. Mol. Cell. Biol. 15:1995;4064-4075.
33. Henderson J.E., Goltzman D. Molecular genetic analysis of growth factor signalling in bone. Henderson J.E., Goltzman D. The osteoporosis primer. 2000;113-128 Cambridge Univ. Press, Cambridge.
34. Horner A., Bord S., Kelsall A., Coleman N., Compston J. Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial growth factor in growing human bone. Bone. 28:2001;65-71.
35. Iwata T., Chen L., Li C.-L., Ovchinnikov D., Behringer R., Francomani C.et al. A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum. Mol. Genet. 9:2000;1603-1613.
36. Karaplis A.C., Luz A., Glowacki J., Bronson R.T., Tybulewicz V.L.J., Kronenberg H.M.et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide (PTHrP) gene. Genes Dev. 8:1994;277-289.
37. Karp S.J., Schipani E., St-Jacques B., Hunzelman J., Kronenberg H., McMahon A.P. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related protein dependent and independent pathways. Development. 2000;543-548.
38. Kilkenny D.M., Hill D.J. Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporally associated with the nuclear trafficking of FGF-2 in proliferating epiphyseal growth plate chondrocytes. Endocrinology. 137:1996;5078-5089.
39. Kobayashi T., Chung U., Schipani E., Starbuck M., Karsenty G., Katagiri T.et al. PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development. 129:2002;2977-2986.
40. Lanske B., Karaplis A.C., Lee K., Luz A., Vortkamp A., Pirro A.et al. PTH/PTHrP receptor in early development and Indian Hedgehog-regulated bone growth. Science. 273:1996;663-666.
41. Legeai-Mallet L., Benoist-Lasselin C., Delezoide A., Munnich A., Bonaventure J. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thantophoric dysplasia. J. Biol. Chem. 273:1998;13007-13014.
42. Li C., Chen L., Iwata T., Kitagawa M., Fu X.-Y., Deng C.-X. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and Ink4 cell cycle inhibitors. Hum. Mol. Genet. 8:1999;35-44.
43. Liu Z., Xu J., Colvin J.S., Ornitz D.M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16:2002;859-869.
44. Long F., Zhang X.M., Karp S., Yang Y., McMahon A.P. Genetic manipulation of hedgehog signalling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development. 128:2001;5099-5108.
45. Mohammadi M., Dionne C.A., Li W., Li N., Spivak T., Honegger A.M.et al. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 358:1992;681-684.
46. Montero A., Okada Y., Tomita M., Ito M., Tsurukami H., Nakamura T.et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 105:2000;1085-1093.
47. Muenke M., Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11:1995;308-313.
48. Naski M.C., Colvin J., Coffin J., Ornitz D.M. Repression of hedgehog signalling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development. 125:1998;4977-4988.
49. Naski M.C., Wang Q., Xu J., Ornitz D.M. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13:1996;233-237.
50. Ohbayashi N., Shibayama M., Kurotaki Y., Imanishi M., Fujimori T., Itoh N.et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16:2002;870-879.
51. Ornitz D., Itoh N. Fibroblast growth factors. Genome Biol. 2:2001;S3005. [Reviews].
52. Ornitz D.M., Xu J., Colvin J.S., McEwen D.G., MacArthur C.A., Coulier F.et al. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271:1996;15292-15297.
53. Parr B., McMahon A. Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb. Nature. 374:1995;350-353.
54. Peters K., Ornitz D., Werner S., Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155:1993;423-430.
55. Poole A.R., Laverty S., Mwale F. Endochondral bone formation and development in the axial and appendicular skeleton. Henderson J.E., Goltzman D. The osteoporosis primer. 2000;3-17 Cambridge Univ. Press, Cambridge, UK.
56. Roach H. New aspects of endochondral ossification in the chick: chondrocyte apoptosis, bone formation by former chondrocytes and acid phosphatase activity in the endochondral bone matrix. J. Bone Miner. Res. 12:1997;795-805.
57. Roach H., Erenpriesa J., Aigner T. Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis. J. Cell Biol. 131:1995;483-494.
58. Sahni M., Ambrosetti D.-C., Mansukhani A., Gertner R., Levy D., Basilico C. FGF signalling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13:1999;1361-1366.
59. Sahni M., Raz R., Coffin J.D., Levy D., Basilico C. STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development. 128:2001;2119-2129.
60. Schipani E., Kruse K., Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science. 268:1995;98-100.
61. Segev G., Chumakov I., Nevo Z., Givol D., Madar-Shapiro L., Sheinin Y.et al. Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization in human FGFR3G380R transgenic mice. Hum. Mol. Genet. 9:2000;249-258.
62. St-Jacques B., Hammerschmidt M., MacMahon A. Indian hedgehog signalling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13:1999;2072-2086.
63. Su W.C.S., Kitagawa M., Xue N., Xie B., Garofalo S., Cho J.et al. Activation of STAT-1 by mutant fibroblast growth factor receptor in thanatophoric dysplasia typeII dwarfism. Nature. 386:1997;288-292.
64. Suda N., Shibata S., Yamazaki K., Kuroda T., Senior P., Beck F.et al. Parathyroid hormone related protein regulates proliferation of condylar hypertrophic chondrocytes. J. Bone Miner. Res. 14:1999;1838-1847.
65. Tucci J., Hammond V., Senior P.V., Gibson A., Beck F. The role of fetal parathyroid hormone related protein in transplacental calcium transport. J. Mol. Endocrinol. 17:1996;159-164.
66. Twal W.O., Vasilatos-Younken R., Gay C.V., Leach R.M. Jr. Isolation and localization of basic fibroblast growth factor-immunoreactive substance in the epiphyseal growth plate. J. Bone Miner. Res. 9:1994;1737-1744.
67. Vortkamp A., Lee K., Lanske B., Segre G.V., Kronenberg H.M., Tabin C.J. Regulation of rate of cartilage differentiation by Indian Hedgehog and PTH-related protein. Science. 273:1996;613-622.
68. Wang Y., Spatz M., Kannan K., Hayk H., Avivi A., Gorivodsky M.et al. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc. Natl. Acad. Sci. U. S. A. 96:1999;4455-4460.
69. Yang Y., Topo L., Lee H., Wu J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development. 130:2003;1003-1015.